Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

Key Considerations for the Use of Bedaquiline [Bdq]

  1. Home
  2. Key Considerations for the Use of Bedaquiline [Bdq]
  3. Key Considerations for the Use of Bedaquiline [Bdq]

Node Status

  • Live
Learning Objectives

Describe about Key Considerations for the Use of Bedaquiline [Bdq] with other drugs. 

Sub Nodes

  • Inclusion and Exclusion Criteria for the Use of Bedaquiline
  • List of Drugs that can be Used Safely or Avoided along with Bedaquiline
  • Additional Considerations for the Use of Newer Drugs in Longer Oral M/XDR-TB Regimen
  • Replacement Sequence in the H Mono/Poly DR-TB
Linked Nodes
DR-TB Treatment Regimens
Newer Anti-TB Drugs: Bedaquiline [Bdq]

KM Node Tags

  • DR-TB and PMDT

Linked Content Page

ID Page title Content Status Content Creator LMS Page Link Language Reviewer
1885 Key Considerations for the Use of Bedaquiline [Bdq] Approved Awele LMSLink English Abhimanyu
Add Content Page


User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International